Interleukin-10 Gene Polymorphism in Parkinsonʹs Disease Patients

Background iology of sporadic Parkinsonʹs disease (PD) is not well established. Recent studies revealed that inflammatory processes might also play an important role in the pathogenesis of PD. We hypothesized that genetically determined differences in the immune response, especially in anti-inflammatory cytokines production, might influence the risk of sporadic PD development and/or onset. To prove this hypothesis, two DNA polymorphisms at IL-10 promoter (−1082 and −519) were examined in sporadic PD patients. s udy enrolled 341 patients with diagnosed idiopathic PD. All cases of secondary parkinsonism were excluded from the study. For the purpose of this study the patients were also divided into two subgroups: group 1: patients with onset of Parkinsonʹs disease, i.e., <50 years of age (early onset) included 60 patients, as well as group 2: patients with onset of Parkinsonʹs disease >50 years of age (late onset) comprising 281 subjects. Control samples were from 315 randomly selected healthy individuals from the same geographical region who were free from signs of parkinsonism as evaluated by consultant neurologists. PCR-RFLP methods were used for genotyping. s tistically significant differences between PD patients and controls were found in the frequency of a single locus (−1082, −519) of IL-10 promoter. Likewise, haplotype analysis did not demonstrate any significant differences between evaluated groups. The frequency of the evaluated IL-10 genotypes was also similar in EOPD and LOPD patients. sions s from our study revealed that the IL-10 (−1082G>A, −592C>A) polymorphism is not a risk factor of sporadic Parkinsonʹs disease in a Polish population.